ABBV - AbbVie Inc.

NYSE - NYSE Delayed Price. Currency in USD
Currency in USD

Valuation Measures

Market Cap (intraday) 5104.35B
Enterprise Value 3136.62B
Trailing P/E 25.77
Forward P/E 17.44
PEG Ratio (5 yr expected) 11.94
Price/Sales (ttm)3.20
Price/Book (mrq)N/A
Enterprise Value/Revenue 34.19
Enterprise Value/EBITDA 69.15

Trading Information

Stock Price History

Beta (3Y Monthly) 0.70
52-Week Change 3-23.86%
S&P500 52-Week Change 33.55%
52 Week High 396.60
52 Week Low 362.66
50-Day Moving Average 366.43
200-Day Moving Average 374.52

Share Statistics

Avg Vol (3 month) 311.44M
Avg Vol (10 day) 39.08M
Shares Outstanding 51.48B
Float 1.48B
% Held by Insiders 10.09%
% Held by Institutions 171.89%
Shares Short (Aug 15, 2019) 451.01M
Short Ratio (Aug 15, 2019) 45.09
Short % of Float (Aug 15, 2019) 43.91%
Short % of Shares Outstanding (Aug 15, 2019) 43.45%
Shares Short (prior month Jul 15, 2019) 444.17M

Dividends & Splits

Forward Annual Dividend Rate 44.28
Forward Annual Dividend Yield 46.07%
Trailing Annual Dividend Rate 34.17
Trailing Annual Dividend Yield 35.91%
5 Year Average Dividend Yield 43.55
Payout Ratio 4144.48%
Dividend Date 3Nov 15, 2019
Ex-Dividend Date 4Oct 11, 2019
Last Split Factor (new per old) 2N/A
Last Split Date 3N/A

Financial Highlights

Fiscal Year

Fiscal Year Ends Dec 31, 2018
Most Recent Quarter (mrq)Jun 30, 2019

Profitability

Profit Margin 12.62%
Operating Margin (ttm)39.97%

Management Effectiveness

Return on Assets (ttm)13.72%
Return on Equity (ttm)N/A

Income Statement

Revenue (ttm)32.62B
Revenue Per Share (ttm)21.87
Quarterly Revenue Growth (yoy)-0.30%
Gross Profit (ttm)25.04B
EBITDA 14.92B
Net Income Avi to Common (ttm)4.09B
Diluted EPS (ttm)2.74
Quarterly Earnings Growth (yoy)-62.60%

Balance Sheet

Total Cash (mrq)5.42B
Total Cash Per Share (mrq)3.66
Total Debt (mrq)37.79B
Total Debt/Equity (mrq)N/A
Current Ratio (mrq)0.89
Book Value Per Share (mrq)-5.79

Cash Flow Statement

Operating Cash Flow (ttm)13.41B
Levered Free Cash Flow (ttm)9.81B